Novartis India Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
899,000.00
995,600.00
1,113,700.00
917,300.00
1,575,200.00
Depreciation, Depletion & Amortization
36,500.00
40,100.00
34,900.00
35,900.00
25,300.00
Other Funds
398,400.00
469,200.00
873,400.00
367,100.00
628,600.00
Funds from Operations
537,100.00
566,500.00
275,200.00
586,100.00
971,900.00
Changes in Working Capital
164,200.00
318,100.00
917,000.00
324,500.00
1,173,000.00
Net Operating Cash Flow
701,300.00
248,400.00
1,192,200.00
261,600.00
2,144,900.00
Capital Expenditures
18,000.00
46,900.00
24,800.00
28,000.00
8,000.00
Sale of Fixed Assets & Businesses
5,500.00
1,200.00
200.00
28,800.00
180,500.00
Purchase/Sale of Investments
570,000.00
1,873,600.00
8,871,400.00
3,559,200.00
20,500.00
Net Investing Cash Flow
582,500.00
6,343,000.00
6,932,800.00
3,560,000.00
152,000.00
Cash Dividends Paid - Total
320,100.00
373,400.00
383,900.00
384,500.00
337,700.00
Issuance/Reduction of Debt, Net
600.00
1,200.00
-
-
-
Net Financing Cash Flow
320,700.00
374,600.00
383,900.00
3,311,500.00
2,676,500.00
Net Change in Cash
201,900.00
6,216,800.00
6,124,500.00
510,100.00
379,600.00
Free Cash Flow
683,300.00
201,500.00
1,167,400.00
233,600.00
2,136,900.00
Other Sources
-
73,551,000.00
1,963,200.00
-
-
Change in Capital Stock
-
-
-
2,927,000.00
2,338,800.00
Other Uses
-
65,288,700.00
-
-
-
About Novartis India
View Profile
